Regulatory T cells in the treatment of disease - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Nature Reviews Drug Discovery Année : 2018

Regulatory T cells in the treatment of disease

Résumé

Regulatory T (Treg) cells suppress inflammation and regulate immune system activity. In patients with systemic or organ-specific autoimmune diseases or those receiving transplanted organs, Treg cells are compromised. Approaches to strengthen Treg cell function, either by expanding them ex vivo and reinfusing them or by increasing the number or capacity of existing Treg cells, have entered clinical trials. Unlike the situation in autoimmunity, in patients with cancer, Treg cells limit the antitumour immune response and promote angiogenesis and tumour growth. Their immunosuppressive function may, in part, explain the failure of many immunotherapies in cancer. Strategies to reduce the function and/or number of Treg cells specifically in tumour sites are being investigated to promote antitumour immunity and regression. Here, we describe the current progress in modulating Treg cells in autoimmune disorders, transplantation and cancer.

Domaines

Immunothérapie
Fichier principal
Vignette du fichier
nrd.2018.148_sans marque (1).pdf (719.5 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-01914953 , version 1 (23-11-2018)

Identifiants

Citer

Amir Sharabi, Maria G Tsokos, Ying Ding, Thomas R Malek, David Klatzmann, et al.. Regulatory T cells in the treatment of disease. Nature Reviews Drug Discovery, 2018, 17 (11), pp.823-844. ⟨10.1038/nrd.2018.148⟩. ⟨hal-01914953⟩
323 Consultations
1039 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More